Avatar - Vernon
Vernonadded this to
Pharma
RedHill Biopharma Announces Peer-Reviewed Publication Demonstrating Therapeutic Potential Of ABC294640 (YELIVA(TM)) In Prostate Cancer

U.S. Patent and Trademark Office

RedHill Biopharma Announces Peer-Reviewed Publication Demonstrating Therapeutic Potential Of ABC294640 (YELIVA(TM)) In Prostate Cancer

TheStreet - GlobeNewswire

• The publication in the peer-reviewed journal Molecular Cancer Research details promising pre-clinical results suggesting ABC294640 significantly …

View on thestreet.com
Avatar - TheStreet

TheStreet

TheStreet brings business and financial news, investing ideas and analysis. We want to help you make money #stockaction

Magazines by TheStreet